Non-invasive sublingual conscious sedation compounded formulations*

iv bag
Patented non-invasive, non-opioid sublingual compounded formulation is now available without the need of individual prescriptions.

The MKO Melt® includes Midazolam, Ketamine HCl, and Ondansetron* and is administered under the tongue. Click here for details on the MKO compounded formulation.

  • Midazolam 3mg (Sedative)
  • Ketamine HCl 25mg (Anesthetic)
  • Ondansetron 2mg (Antiemetic)

The MKO Melt® compounded formulation was developed by physicians and pharmacists as an option for appropriate patients.

MKO Melt

Midazolam, Ketamine HCl, and Ondansetron

IV Free® Administration

The Melt can be administered under the tongue within minutes and typically dissolves within 2-5 minutes.

503B Outsourcing Facility

It is available from ImprimisRx® FDA Registered 503B Outsourcing Facility and can be purchased for $15 per troche without the need of individual prescriptions. FDA Outsourcing Facilities are required to follow cGMP guidelines to safeguard the quality and safety of every compounded medication dispensed. Visit www.imprimisrx.com/order503b/ to order today!

“It is one of the best things we have done for the patient experience, not to mention the surgeon and nurses experience.”

Dr. John Berdahl, Board Certified Ophthalmologist

*For professional use only. ImprimisRx® specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.